Evidence map›Paper›PMID 23221726›Full record

ArticleAmerican journal of epidemiology2013

Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study.

Haixin Li, Alicia Beeghly-Fadiel, Wanqing Wen, Wei Lu, Yu-Tang Gao, Yong-Bing Xiang, Qiuyin Cai, Jirong Long, Jiajun Shi, Kexin Chen and 3 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in American journal of epidemiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. The role of genome sequencing in personalized breast cancer prevention.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  6. Review
  7. PARP inhibitor reduces proliferation and increases apoptosis in breast cancer cells.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2014
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Haixin LiDepartment of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Alicia Beeghly-Fadiel
Wanqing Wen
Wei Lu
Yu-Tang Gao
Yong-Bing Xiang
Qiuyin Cai
Jirong Long
Jiajun Shi
Kexin Chen
Ying Zheng
Xiao Ou Shu
Wei Zheng
Vanderbilt University · USCenters for Disease Control and Prevention · USFudan University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Shanghai Breast Cancer StudyR01CA064277 · NCI · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 1996 to 2012
$4.8M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
Consortium Study to Identify Breast Cancer Susceptibility LociR01CA148667 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LONG, JIRONG, ZHENG, WEI · 2011 to 2015
$3.3M
Genetic Factors for Breast Cancer- A genome Wide StudyR01CA124558 · NCI · VANDERBILT UNIVERSITY · PI ZHENG, WEI · 2008 to 2012
$3.1M
Breast Cancer Survival: Lifestyle and Genetic DeterminantsR01CA118229 · NCI · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 2007 to 2010
$2.9M
Soyfood, Gene Polymorphisms and Endometrial Cancer RiskR01CA092585 · NCI · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 2001 to 2010
$2.3M
Vanderbilt-Shanghai Chronic Disease Research Training ProgramD43TW008313 · FIC · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 2009 to 2013
$1.1M
FIC NIH HHS D43 TW008313NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA064277NCI NIH HHS R01 CA092585NCI NIH HHS R01 CA118229NCI NIH HHS R01 CA124558NCI NIH HHS R01 CA148667NCI NIH HHS R37 CA070867
6 · The paper itself

Abstract

Genome-wide association studies have identified approximately 20 susceptibility loci for breast cancer. A cumulative genetic risk score (GRS) was constructed from 10 variants with replicated associations among participants of the Shanghai Breast Cancer Genetics Study (Shanghai, China, 1996-1998 and 2002-2005). Interactions between the GRS and 11 breast cancer risk factors were evaluated. Among the 6,408 study participants, no evidence of effect modification was found with the GRS for age at menarche, age at menopause, age at first live birth/parity, total months of breastfeeding, family history of breast cancer, history of benign breast disease, hormone replacement therapy, body mass index, waist/hip ratio, or regular physical activity. The effect of the GRS was least homogeneous by duration of menstruation; further analysis indicated a nominally significant interaction with one genetic variant. The mitochondrial ribosomal protein S30 gene (MRPS30) rs10941679 was associated with breast cancer risk only among women with more than 30 years of menstruation (odds ratio = 1.15, 95% confidence interval: 1.05, 1.26). Although this multiplicative interaction reached a nominal significance level (P = 0.037), it did not withstand correction for multiple comparisons. In conclusion, this study revealed no apparent interactions between genome-wide association study-identified genetic variants and breast cancer risk factors in the etiology of this common cancer.

Indexed as

Gene-Environment InteractionPolymorphism, Single NucleotideAdultAgedAged, 80 and overBreast NeoplasmsCase-Control StudiesChinaEffect Modifier, EpidemiologicFemaleGenetic MarkersGenome-Wide Association StudyGenotyping TechniquesHumansLogistic ModelsMiddle AgedGenetic Markers

Identifiers

PMID23221726
PMCPMC3590035
OpenAlexW2130416016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.